One lady with psoriasis all over the body was under allopathic treatment for over one and a half years. She happened to prepare panchagavya for field use and stir the contents with her forearm. After 15 days, the psoriasis in her forearm got fully cured. Following her own intuition, she smeared panchagavya all over the body and to everyones surprise the psoriasis disappeared in 21 days, the Tamil Nadu Agricultural University (TNAU) website claims.
A claim as tall as they come. And most of the claims about panchagavya fall in the same category. Sample this: According to the TNAU website, the magic potion can cure arthritis within two months and help treat several other diseases and conditions such as epilepsy and Parkinsons. It can reduce blood sugar levels and enable diabetic patients to reduce the dose of anti-diabetic drugs. In the case of TB, it can reduce the duration of treatment by a month. For people with AIDS/HIV, even though the blood tests will be positive, patients will exhibit no symptoms of AIDS and lead a normal healthy life thanks to panchagavya.
Even if we keep the lack of evidence aside, it is beyond me why an agriculture university should be discussing the medicinal benefits of panchagavya.
For its proponents, it doesnt matter that cancer is not a single disease and there is no single cure panchagavya can apparently cure it all. Shankarbhai Vegad, a BJP MP from Gujarat told the Rajya Sabha in March 2015: Cow dung and urine can cure cancer. I am witness to it. Cow dung and urine are a 100 per cent cure for cancer.
For the uninitiated, panchagavya is a concoction of cow dung, cow urine, milk, curd and ghee. Along with the five constituents that come from the cow, it also contains jaggery, banana, tender coconut and water.
Now a 19-member committee has been constituted to select projects that can help scientifically validate the benefits of panchagavya, a report in The Hindu says. It will be headed by Union Science and Technology Minister Dr. Harsh Vardhan and other prominent members such as former CSIR Director R.A. Mashelkar, IIT Delhi director Prof. V. Ramgopal Rao and Prof. V.K. Vijay from IIT Delhi. Of course, the committee will be not influenced by three members who have links to the RSS and the VHP!
Indias National Programme Scientific Validation and Research on Panchagavya (SVAROP) will be coordinated by the Department of Science and Technology (DST), Department of Biotechnology (DBT) and Council of Scientific and Industrial Research (CSIR) in collaboration with IIT Delhi.
At a time when fund crunch at CSIR and ICMR is leaving scientists with little financing for front-line research, a national programme will be trying to validate the benefits of panchagavya for various medical and non-medical purposes. Its a pity that there has not been any scientific laboratory and animal studies carried out with results published in peer-reviewed journals to justify a national programme being launched.
Before launching a large programme such as this, there should be pilot projects and early evidence which shows some benefits. There should be some basis that it would work. Unfortunately, we have not seen any evidence in the form of published work in reputed journals, says Dr. Anant Bhan, a researcher in Global Health Policy. There are five components in panchagavya and one would like to know which of those give benefits for which disease, and in which population and at what dosage and duration. Even the composition of the concoction has not been standardised.
For its proponents, it doesnt matter that cancer is not a single disease and there is no single cure panchagavya can apparently cure it all.
Even if we keep an open mind it has to be conditional on good science being followed, Dr. Bhan adds.
Curcumin, the main ingredient of turmeric, which has been studied for various diseases and conditions has been subjected to tough scientific scrutiny. Unlike curcumin, panchagavya is a mixture of five components. Each component is a complex entity. One is not sure which one is causing what, says Prof. G. Padmanaban, former Director of the Indian Institute of Science (IISc) Bengaluru who has studied curcumin extensively. Each component is a highly variable entity and the time of collection of the components and how it is collected varies. There should be quality control for each component. I am not sure if we can establish that. So it will be very difficult to validate panchagavya.
It is always possible to validate panchagavya but the ratio of the five components has to be carefully measured and the dosing has to be meticulously done. Most of the therapeutic components are metabolites and they vary at different times of the year. For example in the case of tulsi leaves, the active component wont be the same in a tender leaf and a matured leaf. So the results will not be the same, says Prof. Gobardhan Das from the Special Centre for Molecular Medicine, Jawaharlal Nehru University (JNU) Delhi.
As scientists we should have an open mind and not be prejudiced. Discoveries cant be made if we dont have an open mind. But we cant approach it with blind faith either. There should be healthy scepticism, says Dr. Girish Sahni, Director-General of CSIR on how he views CSIRs involvement in the National Programme. According to him, a couple of CSIR labs have got some leads on panchagavya, which have not been followed up.
In place of peer-reviewed studies, what we have are patents (No 6410059 and No. 6896907) granted by the United States Patent Trade mark Office. These patents have been granted to an Indian innovation which has proved that cow urine can make antibiotics, anti-fungal agents and also anti-cancer drugs more effective, The Hindu reported in 2002.
What is often not realised is that patents are granted based on uniqueness of an idea or method and surely not on its translation into reality. In the case of drugs, it is not patents but results from animal studies and clinical trials in humans which will attest the effectiveness. Forget animal studies and human clinical trials, panchagavya has not been rigorously tested even on cells lines (in vitro).
The website of the Central AYUSH Ministry lists out many papers published in journals, but none of the links leads to the original papers. What does become apparent is that only a handful of papers discuss panchagavya while a majority deal with cow urine in isolation.
It also becomes abundantly clear that almost all the papers have been published in predatory journals. For instance, the papers such as Antifungal efficacy of panchagavya; Biochemical characterisation and antibacterial activity of panchagavya; Effect of panchagavya ghrita on some neurological parameters in albino rats; and Panchagavya ghrita, a promising drug in ayurvedic psychiatry; have been published in predatory journals. A paper, Evaluation of in-vitro antioxidant activity of panchagavya a traditional ayurvedic preparation, has been published in the International Journal of Pharmaceutical Science and Research that finds mention in a credible list of predatory journals but is also UGC-approved. UGC has many predatory journals included in its white list.
Now this is a case not only of lack of evidence, but also of questionable work published in bogus or predatory journals being showcased by the Central Ministry as evidence.
Here is the original post:
Panchagavya... if cow urine could cure cancer - The Hindu
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]